Log In
BCIQ
Print this Print this
 

BM34

  Manage Alerts
Collapse Summary General Information
Company Biomay AG
Description 
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat ragweed allergy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today